Graph embedding identifies LC-61 with anti-Leishmania activity
A multiscale graph embedding workflow prioritized LC-61, which the study experimentally evaluated against L. infantum. The finding is a specific in-vitro compound result; it does not establish clinical efficacy, safety or a validated target.
Technology: Multiscale-aware graph embedding and machine learning
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Primary article/PubMed and institutional manuscript identify LC-61 and its experimental parasite assay.
- Still unknown: Exact prior structures and broader dose/replication details remain open.
- AI role: Graph embedding ranks candidate molecules for assay; human selection and experimental testing follow.
Evidence sources: https://doi.org/10.1021/acs.jcim.5c02947
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: author-institution primary full-text PDF; PubMed primary metadata. Material checked for the specific claims stated in the record..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.